Original article on Response to Controlled Ovarian Stimulation and Genetic associations in Indian women in JHRS (2023).

A joint study by GeneTech (Dr. Anuradha Udumudi) and Hegde Fertility center (Dr. Vandana Hegde) enabled the identification of potential markers pertaining to response to COS in the Indian population. The study demonstrates that multi gene cumulative risk analysis may offer an additional tool for forecasting a poor responder to COS. Precise identification of the poor response group will facilitate evidence based, customised COS plan for patients with choice of suitable drugs, doses and adjunct therapies, which in turn may lead to improved success rates of treating infertility patients using assisted reproductive technology.